
For patients to maintain or improve their quality of life through their cancer treatment, it is pivotal that they communicate with their health care team.
For patients to maintain or improve their quality of life through their cancer treatment, it is pivotal that they communicate with their health care team.
Clinical trials remain the gold standard when it comes to finding new treatment options for patients, particularly when it comes to renal cell carcinoma. But even if the results are positive and this combination proves to be beneficial, patients should still discuss all of their options with their oncologist to find the right sequence of treatment, says one expert.
Diane Powis spent more than 10 months bouncing from one doctor to the next before finally being “blindsided by” a diagnosis of stage 3 ovarian cancer. But as her initial feelings of isolation and fear wore off, Powis soon learned that she wasn’t alone – and that help and information were out there.
While the threat of COVID-19 still looms across the country, the risks of delaying cancer screenings – or active surveillance for those patients who are currently in treatment – could be greater than people think, says City of Hope’s Dr. Ravi Salgia.
CURE® is proud present the EDUCATED PATIENT® Gastrointestinal Stromal Tumor (GIST) Webinar from Tuesday, January 26, 2021.